Skip to main content
Erschienen in: BMC Public Health 1/2020

Open Access 01.12.2020 | Research article

Prevalence of metabolic syndrome among ethnic groups in China

verfasst von: Xuzhen Qin, Ling Qiu, Guodong Tang, Man-Fung Tsoi, Tao Xu, Lin Zhang, Zhihong Qi, Guangjin Zhu, Bernard M. Y. Cheung

Erschienen in: BMC Public Health | Ausgabe 1/2020

Abstract

Background

Metabolic syndrome (MetS) is common in China, which has a multi-ethnic population of 1·3 billion. We set out to determine the prevalence of MetS and its components in different ethnic groups.

Methods

This nationwide cross-sectional survey involved 24,796 participants from eight ethnicities in six provinces in China from 2008 to 2011. MetS was defined using the modified National Cholesterol Education Program Adult Treatment Panel III criteria. Results were analysed using SPSS version 22·0 in 2018. Logistic regression was used for deriving odds ratios and 95% confidence intervals of risk factors for the MetS.

Results

The prevalence of MetS increased with age from 3·60% to 21·68%. After age standardization, the prevalence of MetS, in descending order, was 35·42% (Korean), 22·82% (Hui), 19·80% (Han), 13·72% (Miao), 12·90% (Tujia), 12·04% (Li), 11·61% (Mongolian), 6·17% (Tibetan). Korean ethnicity was associated with a higher prevalence in five components of MetS, while Tibetan ethnicity was associated with lower prevalence except decreased HDL cholesterol. Logistic regression analyses showed that age, drinking and being non-Tibetan were associated with a higher risk of MetS.

Conclusions

Within one country, albeit a large one, the prevalence of MetS can vary greatly. Chinese of Korean ethnicity had a much higher prevalence than Tibetan ethnicity. Measures to tackle MetS should be tailored to the ethnic groups within a population.
Hinweise
Xuzhen Qin, Ling Qiu and Guodong Tang contributed equally to this work.

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s12889-020-8393-6.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
BMI
Body mass index
CAD
Coronary artery disease
CVD
Cardiovascular disease
DBP
Diastolic blood pressure
GLU
Fasting blood glucose
HDL cholesterol
High-density lipoprotein cholesterol
IDF
World Health Organization (WHO) and International Diabetes Federation
IFG
Impaired fasting glucose
KNHANES
Korean National Health and Nutrition Examination Survey
LDL cholesterol
Low-density lipoprotein cholesterol
MetS
Metabolic syndrome
NCEP: ATPIII
The National Cholesterol Education Program’s Adult Treatment Panel III
ORs, 95% CI
Odds ratios and 95% confidential interval
SBP
Systolic blood pressure
T2DM
Type 2 diabetes
WC
Waist circumference

Background

Metabolic Syndrome (MetS) is a cluster of related abnormalities that include abdominal obesity, insulin resistance, dyslipidaemia and elevated blood pressure [1, 2]. The National Cholesterol Education Program’s Adult Treatment Panel III (NCEP: ATPIII), World Health Organization (WHO) and International Diabetes Federation (IDF) use this syndrome to highlight the risk of patients developing cardiovascular disease (CVD) and type 2 diabetes (T2DM) [1, 3]. We previously reported that the prevalence of MetS in the United States was 33·6% in the adult population [4]. MetS predicts the development of diabetes [5] and hypertension [6], and is also associated with coronary artery disease (CAD) [7] and increased mortality [8].
While the natural history of MetS and how it develops have been well described in Hong Kong Chinese, a large number of observational studies have also been conducted in China, the population of which is mostly of Han ethnicity [9, 10]. A meta-analysis showed that the pooled prevalence of MetS in China was 24·5% among subjects aged over 15 years. Individuals living in urban areas had a higher risk of having MetS than those living in rural areas [11]. However, China is a multi-ethnic country with at least 55 ethnic groups. There are few studies focused on MetS among different ethnic groups in China, and most of these studies focused on a single ethnic group [7, 12, 13]. The heterogeneity in study design, inclusion criteria and definition of MetS makes it difficult to compare the prevalence in different ethnic groups.
Building on the Expansion Investigation of Human Physiology Constant Study in China [14], we made use of unified inclusion criteria and centralized measurements to determine the prevalence of Metabolic Syndrome (MetS) among different ethnicities in six provinces of China using the modified NCEP: ATPIII criteria [15].

Methods

Description of the study

The Expansion Investigation of Human Physiology Constant was a nationwide cross-sectional, random and multistage clustering sampled survey in China that is part of the National Constitution and Health Database in 2008–2011 [16]. Our previous studies based on the National Constitution and Health Database had shown several factors associated with cardiovascular disease [14, 17]. This study was expanded to six provinces and eight ethnic groups according to the geographical, ethnical and economic characteristics from the previous studies. All study personnel was trained with standardised working manuals and surveys before they conducted this study. Sample processing, testing and quality control were conducted by certified personnel in a central laboratory (Department of Laboratory Medicine in Peking Union Medical College Hospital) to ensure the consistency and stability of the measurements.

Subjects

Participants aged 8–86 years were recruited from six provinces (Inner Mongolian, Heilongjiang, Ningxia, Hunan, Yunnan, Sichuan) using a random, multistage cluster-sampling method as shown in Fig. 1. Eight ethnic groups, including Han, Mongolian, Korean, Hui, Miao, Li, Tibetan and Tujia, were enrolled in this study. Inclusion criteria were absence of self-reported systemic diseases, such as CAD, renal disease, autoimmune disease, hypersensitivity, gastrointestinal disease, pulmonary disease, and cancer. Considering different customs of ethnic groups, we included participants aged 8–86. Exclusion criteria included significant abnormalities on physical examination, and having a fever, acute illness, or hospitalization within 15 days. This study was approved by the Ethics Committee of Institute of Basic Medical Sciences Chinese Academy of Medical Sciences (No·005–2008). Written consents were obtained from all participants.

Data collection

Participants were required to complete a demographic questionnaire and a health behaviour questionnaire, which included smoking, alcohol consumption and physical activity. Trained personnel assisted the participants in completing the questionnaires.

Measurements

All participants were asked to avoid smoking and heavy physical activity for at least 2 h before the physical examinations, which included resting blood pressure, height, weight, and waist circumference (WC). Two blood pressure measurements were taken using OMRON HEM-7000 electronic sphygmomanometer (OMRON HealthCare, Kyoto, Japan) after the participants had rested in a sitting position for at least 5 min.
Participants were required to fast for 8 to 12 h before blood sampling. Fasting blood glucose (GLU), total cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL cholesterol), and low-density lipoprotein cholesterol (LDL cholesterol) were analysed using a Hitachi 7020 chemistry analyser (Hitachi, Tokyo, Japan). Body mass index (BMI) was a person’s weight in kilograms divided by the square of height in meters.

Definition of metabolic syndrome

The modified ATP III criteria were applied in the diagnosis of MetS, which requires the presence of at least three out of five factors [15]: (i) Abdominal density as defined by waist circumference ≥ 90 cm in men and ≥ 80 cm in women; (ii) triglycerides ≥1·7 mmol/L; (iii) HDL cholesterol < 1·03 mmol/L in men and < 1·29 mmol/L in women; (iv) systolic blood pressure (SBP) ≥130 mmHg or diastolic blood pressure (DBP) ≥ 85 mmHg; (v) GLU ≥5·6 mmol/L as impaired fasting glucose (IFG).

Statistical analysis

Results were analysed using SPSS version 22·0 (IBM SPSS Statistics, Armonk, NY, USA) in 2018. Descriptive statistics were expressed as frequency (percentage) for categorical data or mean ± SD or median (interquartile range) for continuous variables. Missing data were less than 3% for all included variables. Continuous variables were compared among groups using one-way ANOVA and Kruskal-Wallis tests as appropriate. Categorical variables were compared among groups using Chi-square test. Logistic regression was used to identify the predictors for MetS. Gender, age, ethnicities, exercises, smoking status, drinking status were included in the model. Age groups and gender were entered into the first adjusted model. Other predictor variables were entered stepwise if P < 0·05 and removed if P > 0·10. Exercise was added as a covariate in the second adjusted model and ethnicities, drinking status, smoking status were applied in the third adjusted model. Odds ratios (ORs) and 95% confidential interval (95% CI) were estimated. A two-tailed P < 0·05 was considered statistically significant. Data from the Sixth National Population Census of the People’s Republic of China provided by the National Statistics Bureau of China were used as the standard population. Age-specific prevalence and age-standardized prevalence were estimated from the standard population.

Results

A total of 24,796 participants were enrolled in this study (Fig. 2). The characteristics are summarized in Supplementary Table 1. There was a significant difference in the median age among participants from different provinces and ethnic groups (shown in Supplementary Table 1, 2 and 3). Compared with Hans in the same province, participants from Tibetan, Miao, Tujia, Mongolian, Li ethnic groups were younger (P < 0·001).

The prevalence of MetS in eight ethnic groups of China

The age, gender and ethnic-specific crude and standardised prevalence of MetS are summarised in Table 1. The prevalence of MetS in males (13·5%) was slightly higher than in females (12·6%) (P = 0·28). The prevalence of MetS was substantially higher above age 25 (24·7%) compared with age ≤ 25 (2·3%) (P < 0·001). There was a significant difference in MetS prevalence among ethnic groups (P < 0·001). Korean Chinese had the highest prevalence of 35·42, followed by Hui, Han, Miao, Tujia, Li, Mongolian and Tibetan (Table 1, Fig. 3).
Table 1
The prevalence of MetS stratified by age, gender and eight ethnic groups in China
Ethnic groups
Gender
Age group
Crude prevalence
(%)
Standardised prevalence
(%)
8–12(%)
13–17(%)
18–24(%)
25–39(%)
40–59(%)
> 60(%)
Han
M(%)
0.90(0.31–1.48)
2.64(1.91–3.37)
3.50(2.38–4.62)
24.01(21.70–26.32)
30.22(27.98–32.47)
26.81(23.77–29.86)
14.60(13.81–15.40)
20.59(20.2–21.0)
 
F(%)
1.74(0.92–2.56)
2.73(2.01–3.45)
1.31(0.57–2.05)
9.85(8.35–11.35)
29.28(27.26–31.30)
46.93(43.19–50.67)
14.02(13.26–14.78)
19.63(19.2–20.1)
 
Total(%)
1.31(0.81–1.82)
2.69(2.17–3.20)
2.47(1.78–3.16)
16.40(15.04–17.77)
29.71(28.21–31.21)
36.01(33.57–38.44)
14.30(13.75–14.85)
19.80(19.5–20.1)
Li
M(%)
1.18(0.03–6.38)
2.80(0.76–4.84)
3.23(0.67–9.14)
11.96(8.13–15.78)
16.38(11.62–21.14)
16.00(1.63–30.37)
8.95(7.14–10.75)
9.94(9.0–10.9)
 
F(%)
5.80(0.28–11.31)
4.39(1.73–7.04)
2.70(0.33–9.42)
13.21(9.25–17.18)
21.25(16.39–26.10)
33.33(15.55–51.11)
12.62(10.51–14.73)
14.15(13.1–15.2)
 
Total(%)
3.25(0.45–6.05)
3.56(1.90–5.22)
2.99(0.41–5.58)
12.59(9.83–15.35)
19.01(15.59–22.43)
25.00(13.23–36.77)
10.77(9.38–12.16)
12.04(11.3–12.7)
Miao
M(%)
0.00
0.00
12.50(0.32–52.65)
22.45(10.77–34.13)
22.22(11.96–32.49)
18.52(3.87–33.17)
12.06(8.08–16.04)
15.83(13.7–18.0)
 
F(%)
0.00
0.00
10.00(0.25–44.50)
3.85(0.10–19.64)
24.53(12.94–36.11)
0.00
7.69(3.95–11.43)
8.84(6.9–10.8)
 
Total(%)
0.00
0.00
11.11(1.38–34.71)
16.00(7.70–24.30)
23.28(15.59–30.97)
14.29(2.69–25.88)
10.18(7.39–12.96)
13.72(12.2–15.3)
Mongolian
M(%)
0.45(0.01–2.50)
2.25(0.07–4.42)
1.52(0.04–8.16)
17.72(9.30–26.14)
22.99(14.15–31.83)
20.83(4.59–37.08)
6.87(4.93–8.81)
14.46(13.2–15.8)
 
F(%)
2.75(0.58–4.92)
1.83(0.05–3.62)
3.64(0.14–7.13)
6.67(2.86–10.47)
14.38(8.94–19.81)
36.11(20.42–51.80)
6.73(5.10–8.36)
10.40(9.4–11.4)
 
Total(%)
1.59(0.42–2.77)
2.02(0.63–3.41)
2.84(0.39–5.30)
10.25(6.44–14.05)
17.41(12.68–22.14)
30.00(18.40–41.60)
6.79(5.54–8.03)
11.61(10.8–12.4)
Korean
M(%)
4.76(0.99–13.29)
4.28(1.38–7.18)
6.90(0.85–22.77)
42.86(29.90–55.82)
44.83(34.38–55.28)
46.99(36.25–57.73)
22.77(19.11–26.43)
37.60(35.6–39.6)
 
F(%)
3.80(0.79–10.70)
6.07(3.42–8.72)
4.55(0.12–22.84)
16.46(8.28–24.63)
45.83(35.87–55.80)
61.90(52.62–71.19)
20.89(17.87–23.92)
34.52(32.8–36.2)
 
Total(%)
4.23(0.92–7.53)
5.40(3.42–7.38)
5.88(1.23–16.24)
27.41(19.88–34.93)
45.36(38.14–52.57)
55.32(48.21–62.43)
21.68(19.35–24.02)
35.42(34.1–36.7)
Hui
M(%)
2.00(0.24–7.04)
1.08(0.22–3.12)
5.99(2.39–9.59)
35.51(26.45–44.58)
36.60(29.82–43.38)
34.15(19.63–48.66)
15.56(13.17–17.94)
25.32(23.9–26.7)
 
F(%)
1.63(0.20–5.75)
1.71(0.22–3.19)
0.98(0.12–3.50)
12.39(6.31–18.46)
30.30(23.29–37.32)
75.00(57.68–92.32)
9.87(7.94–11.80)
21.83(20.5–23.1)
 
Total(%)
1.79(0.05–3.54)
1.40(0.44–2.37)
3.23(1.43–5.03)
23.64(18.02–29.25)
33.70(28.81–38.59)
49.23(37.08–61.38)
12.66(11.13–14.19)
22.82(21.9–23.8)
Tujia
M(%)
0.00
0.00
4.76(0.58–16.16)
11.69(4.51–18.86)
26.00(17.40–34.60)
15.63(3.04–28.21)
12.61(9.05–16.18)
13.45(11.7–15.2)
 
F(%)
0.00
0.00
3.70(0.09–18.97)
1.45(0.04–7.81)
18.75(7.71–29.79)
39.13(19.19–59.08)
8.40(4.88–11.93)
11.99(10.0–14.0)
 
Total(%)
0.00
0.00
4.35(0.91–12.18)
6.85(2.75–10.95)
23.65(16.80–30.49)
25.45(13.94–36.97)
10.86(8.31–13.41)
12.90(11.6–14.2)
Tibetan
M(%)
1.04(0.03–5.67)
0.39(0.01–2.17)
1.69(0.04–9.09)
11.88(5.57–18.19)
18.75(7.71–29.79)
11.11(2.35–29.16)
4.62(2.92–6.32)
9.38(8.2–10.5)
 
F(%)
0.00
1.67(0.22–3.12)
1.32(0.03–7.11)
5.10(1.66–8.54)
7.22(2.07–12.37)
5.88(0.15–28.69)
2.82(1.66–3.98)
4.20(3.5–4.9)
 
Total(%)
0.44(0.01–2.41)
1.08(0.22–1.94)
1.48(0.18–5.25)
7.75(4.49–11.01)
11.03(5.93–16.13)
9.09(0.60–17.59)
3.59(2.60–4.58)
6.17(5.6–6.8)
Data is expressed as prevalence (95% confidence interval)

The prevalence of MetS components

Figure 4 shows the prevalence of components of MetS in different ethnic groups. The highest prevalence of abdominal obesity, hyperlipidaemia, decreased HDL cholesterol, elevated blood pressure and IFG were found in Han, Li, Hui, Li and Korean ethnicities, respectively; while the lowest prevalence of the components of MetS appeared in Li and Tibetan ethnicities (Fig. 4). In all ethnic groups, the prevalence of decreased HDL cholesterol and elevated blood pressure were the two highest among the five components, while IFG was less prevalent, especially in Miao, Mongolian, Tibetan, Hui and Tujia ethnicities.

Predictors for MetS

Predictors for MetS are summarized in Table 2. Age, gender, smoking, alcohol consumption and ethnic groups were all significant risk factors for MetS in the crude model (p < 0·001, p = 0·027, p < 0·001, p < 0·001, p < 0·001, respectively). Compared to females, males had an increased risk of MetS [OR (95% CI): 1·087 (1·009–1·171), p = 0·027]. However, maleness [1·028 (0·930–1·137), p = 0·059] and smoking [0·908 (0·806–1·022), p = 0·110] were not significant factors for MetS after multivariable adjustment. Compared to participants aged 8 to 12 years, the OR increased with age, and was highest in participants aged 60 to 86 years [34·117 (24·673–47·177), p < 0·001]. Relative to Tibetans, all other ethnicities were associated with increased risk of MetS. Korean Chinese had the highest adjusted risk for MetS [5·989 (4·249–8·442), p < 0.001], followed by Hui [4·020 (2·859–5·653), p < 0.001], Han [2·975 (2·194–4·034), p < 0.001], Li [2·096 (1·487–2·954), p < 0·001], Miao [1·961 (1·262–3·048), p = 0·003], Mongolian [1·835 (1·272–2·648), p = 0·001] and Tujia [1·753 (1·166–2·637), p = 0·007] ethnicities. MetS was not significantly associated with exercise in both crude and adjusted models (P = 0·140, P = 0·710, P = 0·710, P = 0·905, respectively).
Table 2
Predictors of metabolic syndrome
Parameters
Crude model
Adjusted model 1
Adjusted model 2
Adjusted model 3
Male
1·087 (1·009–1·171)
1·110 (1·024–1·202)
1·110 (1·025–1·203)
1·028 (0·930–1·137)
Exercise
0·941 (0·867–1·020)
1·017 (0·931–1·110)
1·017 (0·931–1·110)
1·006 (0·911–1·111)
Smoking Status
1·867 (1·702–2·048) ^
0·977 (0·873–1·093)
0·979 (0·875–1·096)
0·908 (0·806–1·022)
Drinking Status
2·159 (1·975–2·360) ^
1·322 (1·186–1·472) ^
1·320 (1·184–1·470) ^
1·348 (1·203–1·509) ^
Age groups
8–12
1 (reference)
1 (reference)
1 (reference)
1(reference)
 
13–17
1·767 (1·282–2·435)
1·770 (1·285–2·440) ^
1·769 (1·283–2·438) ^
1·712 (1·208–2·425)
 
18–24
1·870 (1·306–2·677)
1·867 (1·304–2·674)
1·863 (1·301–2·669)
1·727 (1·176–2·535)
 
25–39
12·191 (9·090–16·350) ^
12·242 (9·128–16·418) ^
12·238 (9·125–16·414) ^
11·67 (8·452–16·113) ^
 
40–59
26·041 (19·516–34·747) ^
26·16 (19·605–34·907) ^
26·162 (19·606–34·910) ^
24·583 (17·892–33·776) ^
 
60–86
38·350 (28·512–51·584) ^
38·225 (28·418–51·416) ^
38·176 (28·38–51·354) ^
34·117 (24·673–47·177) ^
Ethnic groups
Tibetan
1 (reference)
1 (reference)
1 (reference)
1(reference)
 
Han
4·482 (3·358–5·982) ^
2·917 (2·165–3·930) ^
2·916 (2·165–3·929) ^
2·975 (2·194–4·034) ^
 
Li
3·243 (2·356–4·465) ^
1·991 (1·431–2·771) ^
1·984 (1·417–2·778) ^
2·096 (1·487–2·954) ^
 
Miao
3·043 (2·004–4·620) ^
1·877 (1·213–2·903)
1·877 (1·214–2·904)
1·961 (1·262–3·048)
 
Mongolian
1·955 (1·382–2·765) ^
1·815 (1·266–2·602)
1·815 (1·266–2·602)
1·835 (1·272–2·648)
 
Korean
7·436 (5·419–10·205) ^
6·116 (4·377–8·547) ^
6·112 (4·373–8·543) ^
5·989 (4·249–8·442) ^
 
Hui
3·893 (2·835–5·345) ^
3·629 (2·605–5·054) ^
3·625 (2·602–5·052) ^
4·020 (2·859–5·653) ^
 
Tujia
3·271 (2·219–4·824) ^
1·721 (1·151–2·575)
1·722 (1·151–2·576)
1·753 (1·166–2·637)
Data is expressed as odds ratio (95% confidence interval)
^p < 0·001
Adjusted model 1: adjusted for gender, age groups
Adjusted model 2: adjusted for gender, age groups and exercises
Adjusted model 3: adjusted for gender, age groups, exercises, ethnicities, smoking status and drinking status

Discussion

This study is the first large-scale multi-ethnic investigation of the prevalence of MetS in China. With 24,796 participants, it had sufficient power to estimate and compare prevalence in subgroups. Such comparisons are also valid and reliable because we had standardised protocols, rigorous quality control and a central clinical laboratory for measurements. The large sample size, standardised measurements and the quality control allowed us to have accurate estimates of the prevalence of MetS in the general population in China. It is a strength of the study to recruit from the age of 8 to 86, which is an uncommonly wide range for an epidemiological study. The study did not recruit subjects below the age of 8 or above the age of 86 for practical reasons.
The prevalence of MetS in Hans in the present study was higher than a previous national study in China [18], but lower or similar to the prevalence in US and Europe [19, 20]. Due to economic development, consumption of dairy products and fast foods had doubled [21, 22], which might have contributed to the increasing trend in MetS. The prevalence of MetS was slightly higher in men in this study, in contrast to some other populations [23].
The prevalence of MetS in Korean, Hui and Mongolian Chinese in our study is relatively higher than previous studies’ in these ethnicities [2426]. A study using the Korean National Health and Nutrition Examination Survey (KNHANES) data from 2008 to 2013 reported that the prevalence of MetS among the Korean participants aged ≥20 years was 28·9% according to the modified NCEP: ATPIII definition [25]. A study conducted among rural adults in Ningxia in 2008 reported that the age-adjusted prevalence of MetS was 13·7% with International Diabetes Federation definition [26]. In Mongolians aged over 18 years, the prevalence of MetS in men was higher than in women (36·7% vs. 17·8%) [24]. However, a study of Tibetan immigrants in India aged over 20 years reported a prevalence of 10·6% in men and 33·3% in women [27]. In our study, Tibetans had a much lower prevalence of MetS as a result of possible volunteer bias.
This study revealed that the prevalence of the components of MetS varied greatly in different ethnicities. These differences may be due to genetic factors and environmental factors, which include diet and lifestyle. A randomized dietary and behavioural interventional study showed that a Tibetan diet reduced body weight and BMI in patients with CAD and MetS [28]. This might be the reason why Tibetans in our study had a low prevalence of MetS. The increased prevalence of MetS in Korean ethnicity might also be explained by diet, since it has been shown that dietary intakes of total fat and saturated fatty acids were significantly associated with MetS [29].
The association of gender with MetS is controversial [3032]. In this study, the association of maleness with MetS was weak and became not significant in the multivariable model. In previous studies, it have been shown that advanced age and drinking status were both associated with higher risk of MetS, while the association with exercise and smoking status was equivocal [3335]. Our finding that Chinese of Korean and Tibetan ethnicities had the highest and lowest prevalence for MetS respectively should prompt further studies to explore the possible causes of ethnic difference in the risk of developing MetS. Such studies should include a detailed dietary and lifestyle survey, and a study of socioeconomic and genetic factors.

Limitations

There were some limitations in this study. China is a large country, so 24,796 participants represent only a small fraction of the total population. We were unable to study minorities in very remote parts of China. Different ethnic groups have different religious beliefs and customs, and these may account for some of the differences.

Conclusions

In this large multi-ethnic population-based survey, the age-standardized prevalence of MetS varied greatly in different ethnic groups, ranging from 6·18% to 35·43%. Korean ethnicity was associated with a higher prevalence of MetS and its components, while Tibetan ethnicity was associated with a lower prevalence of MetS and its components except decreased HDL cholesterol.

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s12889-020-8393-6.

Acknowledgements

We acknowledge the assistance of the late Prof. James Miller from the University of Louisville in manuscript preparation. QXZ was the recipient of a Dr. Cheng Yu Tung Fellowship. We declare that the abstract of this manuscript has been presented at a research conference, the Lancet-CAMS Health Summit, 2019.
We clarify the source of materials used in our study, and any permissions to collect such samples comply with institutional, national, or international guidelines. Written informed consent was obtained from participants or a parent or guardian for participants under 16 years old.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Alberti KGMM, et al. The metabolic syndrome: a new worldwide definition. Lancet. 2005;366(9491):1059–62.CrossRef Alberti KGMM, et al. The metabolic syndrome: a new worldwide definition. Lancet. 2005;366(9491):1059–62.CrossRef
2.
Zurück zum Zitat Cheung BM, Thomas GN. The metabolic syndrome and vascular disease in Asia. Cardiovasc Hematol Disord Drug Targets. 2007;7(2):79–85.CrossRef Cheung BM, Thomas GN. The metabolic syndrome and vascular disease in Asia. Cardiovasc Hematol Disord Drug Targets. 2007;7(2):79–85.CrossRef
3.
Zurück zum Zitat Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285(19):2486–97.CrossRef Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285(19):2486–97.CrossRef
4.
Zurück zum Zitat Cheung BM, et al. Prevalence of the metabolic syndrome in the United States National Health and nutrition examination survey 1999-2002 according to different defining criteria. J Clin Hypertens (Greenwich). 2006;8(8):562–70.CrossRef Cheung BM, et al. Prevalence of the metabolic syndrome in the United States National Health and nutrition examination survey 1999-2002 according to different defining criteria. J Clin Hypertens (Greenwich). 2006;8(8):562–70.CrossRef
5.
Zurück zum Zitat Cheung BM, et al. Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care. 2007;30(6):1430–6.CrossRef Cheung BM, et al. Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care. 2007;30(6):1430–6.CrossRef
6.
Zurück zum Zitat Cheung BM, et al. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong cardiovascular risk factor prevalence Study-2 (CRISPS2). Am J Hypertens. 2008;21(1):17–22.CrossRef Cheung BM, et al. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong cardiovascular risk factor prevalence Study-2 (CRISPS2). Am J Hypertens. 2008;21(1):17–22.CrossRef
7.
Zurück zum Zitat Gui MH, et al. Effect of metabolic syndrome score, metabolic syndrome, and its individual components on the prevalence and severity of angiographic coronary artery disease. Chin Med J. 2017;130(6):669–77.CrossRef Gui MH, et al. Effect of metabolic syndrome score, metabolic syndrome, and its individual components on the prevalence and severity of angiographic coronary artery disease. Chin Med J. 2017;130(6):669–77.CrossRef
8.
Zurück zum Zitat Cheung BM, et al. Components of the metabolic syndrome predictive of its development: a 6-year longitudinal study in Hong Kong Chinese. Clin Endocrinol. 2008;68(5):730–7.CrossRef Cheung BM, et al. Components of the metabolic syndrome predictive of its development: a 6-year longitudinal study in Hong Kong Chinese. Clin Endocrinol. 2008;68(5):730–7.CrossRef
9.
Zurück zum Zitat Gu D, et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet. 2005;365(9468):1398–405.CrossRef Gu D, et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet. 2005;365(9468):1398–405.CrossRef
10.
Zurück zum Zitat Yang G. Salt intake in individuals with metabolic syndrome. Lancet. 2009;373(9666):792–4.CrossRef Yang G. Salt intake in individuals with metabolic syndrome. Lancet. 2009;373(9666):792–4.CrossRef
11.
Zurück zum Zitat Li R, et al. Prevalence of metabolic syndrome in mainland China: a meta-analysis of published studies. BMC Public Health. 2016;16(1):296.CrossRef Li R, et al. Prevalence of metabolic syndrome in mainland China: a meta-analysis of published studies. BMC Public Health. 2016;16(1):296.CrossRef
12.
Zurück zum Zitat He J, et al. The optimal ethnic-specific waist-circumference cut-off points of metabolic syndrome among low-income rural Uyghur adults in far Western China and implications in preventive public health. Int J Environ Res Public Health. 2017;14(2):158.CrossRef He J, et al. The optimal ethnic-specific waist-circumference cut-off points of metabolic syndrome among low-income rural Uyghur adults in far Western China and implications in preventive public health. Int J Environ Res Public Health. 2017;14(2):158.CrossRef
13.
Zurück zum Zitat Yan YZ, et al. Association of Insulin Resistance with glucose and lipid metabolism: ethnic heterogeneity in far Western China. Mediat Inflamm. 2016;2016:1–8. Yan YZ, et al. Association of Insulin Resistance with glucose and lipid metabolism: ethnic heterogeneity in far Western China. Mediat Inflamm. 2016;2016:1–8.
14.
Zurück zum Zitat Qin X, et al. Association between gamma-glutamyltransferase and prehypertension. Mol Med Rep. 2012;5(4):1092–8.CrossRef Qin X, et al. Association between gamma-glutamyltransferase and prehypertension. Mol Med Rep. 2012;5(4):1092–8.CrossRef
15.
Zurück zum Zitat Grundy SM, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735–52.CrossRef Grundy SM, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735–52.CrossRef
16.
Zurück zum Zitat Xu T, Zhu GJ, Han SM. Study of zero-inflated regression models in a large-scale population survey of sub-health status and its influencing factors. Chin Med Sci J. 2017;32(4):218–25.CrossRef Xu T, Zhu GJ, Han SM. Study of zero-inflated regression models in a large-scale population survey of sub-health status and its influencing factors. Chin Med Sci J. 2017;32(4):218–25.CrossRef
17.
Zurück zum Zitat Wu J, et al. Prevalence and clustering of major cardiovascular risk factors in China: a recent cross-sectional survey. Medicine (Baltimore). 2016;95(10):e2712.CrossRef Wu J, et al. Prevalence and clustering of major cardiovascular risk factors in China: a recent cross-sectional survey. Medicine (Baltimore). 2016;95(10):e2712.CrossRef
18.
Zurück zum Zitat He Y, et al. Prevalence of metabolic syndrome and individual metabolic abnormalities in China, 2002-2012. Asia Pac J Clin Nutr. 2019;28(3):621–33.PubMed He Y, et al. Prevalence of metabolic syndrome and individual metabolic abnormalities in China, 2002-2012. Asia Pac J Clin Nutr. 2019;28(3):621–33.PubMed
19.
Zurück zum Zitat Moore JX, Chaudhary N, Akinyemiju T. Metabolic syndrome prevalence by race/ethnicity and sex in the United States, National Health and nutrition examination survey, 1988–2012. Prev Chronic Dis. 2017;14:160287.CrossRef Moore JX, Chaudhary N, Akinyemiju T. Metabolic syndrome prevalence by race/ethnicity and sex in the United States, National Health and nutrition examination survey, 1988–2012. Prev Chronic Dis. 2017;14:160287.CrossRef
20.
Zurück zum Zitat Agyemang C, et al. A cross-national comparative study of metabolic syndrome among non-diabetic Dutch and English ethnic groups. Eur J Pub Health. 2013;23(3):447–52.CrossRef Agyemang C, et al. A cross-national comparative study of metabolic syndrome among non-diabetic Dutch and English ethnic groups. Eur J Pub Health. 2013;23(3):447–52.CrossRef
21.
Zurück zum Zitat Xue H, et al. Time trends in fast food consumption and its association with obesity among children in China. PLoS One. 2016;11(3):e0151141.CrossRef Xue H, et al. Time trends in fast food consumption and its association with obesity among children in China. PLoS One. 2016;11(3):e0151141.CrossRef
22.
Zurück zum Zitat Zhao Y, et al. Fast food consumption and its associations with obesity and hypertension among children: results from the baseline data of the childhood obesity study in China mega-cities. BMC Public Health. 2017;17(1):933.CrossRef Zhao Y, et al. Fast food consumption and its associations with obesity and hypertension among children: results from the baseline data of the childhood obesity study in China mega-cities. BMC Public Health. 2017;17(1):933.CrossRef
23.
Zurück zum Zitat Pucci G, et al. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: a review of the literature. Pharmacol Res. 2017;120:34–42.CrossRef Pucci G, et al. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: a review of the literature. Pharmacol Res. 2017;120:34–42.CrossRef
24.
Zurück zum Zitat You L, et al. Prevalence of hyperuricemia and the relationship between serum uric acid and metabolic syndrome in the Asian Mongolian area. J Atheroscler Thromb. 2014;21(4):355–65.CrossRef You L, et al. Prevalence of hyperuricemia and the relationship between serum uric acid and metabolic syndrome in the Asian Mongolian area. J Atheroscler Thromb. 2014;21(4):355–65.CrossRef
25.
Zurück zum Zitat Tran BT, Jeong BY, Oh JK. The prevalence trend of metabolic syndrome and its components and risk factors in Korean adults: results from the Korean National Health and nutrition examination survey 2008-2013. BMC Public Health. 2017;17(1):71.CrossRef Tran BT, Jeong BY, Oh JK. The prevalence trend of metabolic syndrome and its components and risk factors in Korean adults: results from the Korean National Health and nutrition examination survey 2008-2013. BMC Public Health. 2017;17(1):71.CrossRef
26.
Zurück zum Zitat Zhao Y, et al. Prevalence of the metabolic syndrome among rural original adults in NingXia, China. BMC Public Health. 2010;10(1):140.CrossRef Zhao Y, et al. Prevalence of the metabolic syndrome among rural original adults in NingXia, China. BMC Public Health. 2010;10(1):140.CrossRef
27.
Zurück zum Zitat Lin BY, et al. The prevalence of obesity and metabolic syndrome in Tibetan immigrants living in high altitude areas in Ladakh, India. Obes Res Clin Pract. 2018;12(4):365–71.CrossRef Lin BY, et al. The prevalence of obesity and metabolic syndrome in Tibetan immigrants living in high altitude areas in Ladakh, India. Obes Res Clin Pract. 2018;12(4):365–71.CrossRef
28.
Zurück zum Zitat von Haehling S, et al. Weight reduction in patients with coronary artery disease: comparison of traditional Tibetan medicine and Western diet. Int J Cardiol. 2013;168(2):1509–15.CrossRef von Haehling S, et al. Weight reduction in patients with coronary artery disease: comparison of traditional Tibetan medicine and Western diet. Int J Cardiol. 2013;168(2):1509–15.CrossRef
29.
Zurück zum Zitat Lee KW, et al. Association of dietary intakes of total and subtypes of fat substituted for carbohydrate with metabolic syndrome in Koreans. Endocr J. 2016;63(11):991–9.CrossRef Lee KW, et al. Association of dietary intakes of total and subtypes of fat substituted for carbohydrate with metabolic syndrome in Koreans. Endocr J. 2016;63(11):991–9.CrossRef
30.
Zurück zum Zitat Bentley-Lewis R, Koruda K, Seely EW. The metabolic syndrome in women. Nat Clin Pract Endocrinol Metab. 2007;3(10):696–704.CrossRef Bentley-Lewis R, Koruda K, Seely EW. The metabolic syndrome in women. Nat Clin Pract Endocrinol Metab. 2007;3(10):696–704.CrossRef
31.
Zurück zum Zitat Vryonidou A, et al. MECHANISMS IN ENDOCRINOLOGY: metabolic syndrome through the female life cycle. Eur J Endocrinol. 2015;173(5):R153–63.CrossRef Vryonidou A, et al. MECHANISMS IN ENDOCRINOLOGY: metabolic syndrome through the female life cycle. Eur J Endocrinol. 2015;173(5):R153–63.CrossRef
32.
Zurück zum Zitat Ong KL, et al. Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension. Hypertension. 2008;51(4):1142–8.CrossRef Ong KL, et al. Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension. Hypertension. 2008;51(4):1142–8.CrossRef
33.
Zurück zum Zitat Huang JH, et al. Lifestyle factors and metabolic syndrome among workers: the role of interactions between smoking and alcohol to nutrition and exercise. Int J Environ Res Public Health. 2015;12(12):15967–78.CrossRef Huang JH, et al. Lifestyle factors and metabolic syndrome among workers: the role of interactions between smoking and alcohol to nutrition and exercise. Int J Environ Res Public Health. 2015;12(12):15967–78.CrossRef
34.
Zurück zum Zitat Yu M, et al. Associations of cigarette smoking and alcohol consumption with metabolic syndrome in a male Chinese population: a cross-sectional study. J Epidemiol. 2014;24(5):361–9.CrossRef Yu M, et al. Associations of cigarette smoking and alcohol consumption with metabolic syndrome in a male Chinese population: a cross-sectional study. J Epidemiol. 2014;24(5):361–9.CrossRef
35.
Zurück zum Zitat Kwasniewska M, et al. Smoking status, the menopausal transition, and metabolic syndrome in women. Menopause. 2012;19(2):194–201.CrossRef Kwasniewska M, et al. Smoking status, the menopausal transition, and metabolic syndrome in women. Menopause. 2012;19(2):194–201.CrossRef
Metadaten
Titel
Prevalence of metabolic syndrome among ethnic groups in China
verfasst von
Xuzhen Qin
Ling Qiu
Guodong Tang
Man-Fung Tsoi
Tao Xu
Lin Zhang
Zhihong Qi
Guangjin Zhu
Bernard M. Y. Cheung
Publikationsdatum
01.12.2020
Verlag
BioMed Central
Erschienen in
BMC Public Health / Ausgabe 1/2020
Elektronische ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-020-8393-6

Weitere Artikel der Ausgabe 1/2020

BMC Public Health 1/2020 Zur Ausgabe